Announcements Trials
Browse Landscape

Status

Terminated 2Unknown 1Completed 1Approved for marketing 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Genitourinary 1

Conditions

Water Intoxication 1Osteosarcoma 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Acute Kidney Injury 1

Interventions

Methotrexate 5Drug Therapy 5apatinib 4Neoadjuvant Therapy 4Doxorubicin 3camrelizumab 2Ifosfamide 2Cisplatin 2trilaciclib 1spartalizumab 1palbociclib 1isophosphamide mustard 1irinotecan sucrosofate 1glucarpidase 1endostar protein 1Zoledronic Acid 1Vinorelbine 1Triptorelin Pamoate 1Trabectedin 1Therapeutics 1Thalidomide 1TQ-B3525 1Psychiatric Rehabilitation 1Nivolumab 1Neuropsychological Tests 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Microbiota 1Metabolome 1Magnetic Resonance Spectroscopy 1Lithium Carbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Osteosarcoma × glucarpidase × Clear all
NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

BTG International Inc.

Unknown
1,000 enrolled
GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡